相似文献
1
Imaging for the diagnosis and management of ductal carcinoma in situ.
J Natl Cancer Inst Monogr. 2010;2010(41):214-7. doi: 10.1093/jncimonographs/lgq037.
2
Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.
Acta Radiol. 2011 Jun 1;52(5):481-7. doi: 10.1258/ar.2011.100357. Epub 2011 Mar 28.
3
Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
AJR Am J Roentgenol. 2019 Apr;212(4):919-924. doi: 10.2214/AJR.18.20306. Epub 2019 Feb 4.
4
Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
Acta Radiol. 2022 May;63(5):586-595. doi: 10.1177/02841851211006319. Epub 2021 Apr 22.
5
Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation.
Semin Diagn Pathol. 1994 Aug;11(3):181-92.
6
Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
AJR Am J Roentgenol. 2003 Dec;181(6):1679-84. doi: 10.2214/ajr.181.6.1811679.
7
Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Acad Radiol. 2017 Nov;24(11):1364-1371. doi: 10.1016/j.acra.2017.05.017. Epub 2017 Jul 10.
8
Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography.
Clin Imaging. 2016 Nov-Dec;40(6):1207-1212. doi: 10.1016/j.clinimag.2016.08.001. Epub 2016 Aug 6.
9
Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Acad Radiol. 2017 Sep;24(9):1139-1147. doi: 10.1016/j.acra.2017.03.013. Epub 2017 May 11.
10
Mammographic features predicting an extensive intraductal component in early-stage infiltrating ductal carcinoma.
AJR Am J Roentgenol. 1992 Feb;158(2):269-72. doi: 10.2214/ajr.158.2.1309620.
引用本文的文献
1
Structural analysis of a micron-sized deposit of Cu in an insulin ball from a person with diabetes.
Commun Med (Lond). 2025 May 7;5(1):158. doi: 10.1038/s43856-025-00889-5.
2
Assessing the malignancy of suspicious breast microcalcifications: the role of contrast enhanced mammography.
Radiol Med. 2024 Jun;129(6):855-863. doi: 10.1007/s11547-024-01813-y. Epub 2024 Apr 12.
3
A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast.
Cancers (Basel). 2022 Jan 12;14(2):370. doi: 10.3390/cancers14020370.
4
Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma to Invasive Ductal Carcinoma.
Clin Cancer Res. 2020 Jul 15;26(14):3682-3693. doi: 10.1158/1078-0432.CCR-19-2563. Epub 2020 Mar 27.
5
Educational Case: Ductal Carcinoma In Situ (DCIS).
Acad Pathol. 2019 Nov 21;6:2374289519888727. doi: 10.1177/2374289519888727. eCollection 2019 Jan-Dec.
6
Deposition of calcium in an in vitro model of human breast tumour calcification reveals functional role for ALP activity, altered expression of osteogenic genes and dysregulation of the TRPM7 ion channel.
Sci Rep. 2019 Jan 24;9(1):542. doi: 10.1038/s41598-018-36496-9.
7
Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status.
Eur Radiol. 2013 Aug;23(8):2072-8. doi: 10.1007/s00330-013-2827-9. Epub 2013 Mar 20.
8
Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain.
Eur Radiol. 2011 Sep;21(9):2020-8. doi: 10.1007/s00330-011-2143-1. Epub 2011 May 11.
本文引用的文献
1
Comparison of acquisition parameters and breast dose in digital mammography and screen-film mammography in the American College of Radiology Imaging Network digital mammographic imaging screening trial.
AJR Am J Roentgenol. 2010 Feb;194(2):362-9. doi: 10.2214/AJR.08.2114.
2
Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):45-51. doi: 10.1158/1055-9965.EPI-05-0349.
3
Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations.
Eur J Radiol. 2005 Apr;54(1):55-61. doi: 10.1016/j.ejrad.2004.11.019.
4
Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
Lancet. 2003 Apr 26;361(9367):1405-10. doi: 10.1016/S0140-6736(03)13143-1.
5
Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy.
Radiology. 2001 Nov;221(2):495-503. doi: 10.1148/radiol.2212010164.
6
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
Lancet. 1999 Jun 12;353(9169):1993-2000. doi: 10.1016/S0140-6736(99)05036-9.
7
The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
AJR Am J Roentgenol. 1998 Jul;171(1):35-40. doi: 10.2214/ajr.171.1.9648759.
8
Incidence of and treatment for ductal carcinoma in situ of the breast.
JAMA. 1996 Mar 27;275(12):913-8.
9
New Swedish breast cancer detection results for women aged 40-49.
Cancer. 1993 Aug 15;72(4 Suppl):1437-48. doi: 10.1002/1097-0142(19930815)72:4+<1437::aid-cncr2820721405>3.0.co;2-m.
10
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.
Ann Surg. 1980 Aug;192(2):139-47. doi: 10.1097/00000658-198008000-00001.
Zotero 插件